Compound ID | 168
Class: Immunomodulator (pepducin class)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Preliminary testing against P. aeruginosa,E. faecalis, E. coli and S. aureus |
| Institute where first reported: | Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden |
| Year first mentioned: | 2010 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |